{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T01:03:06Z","timestamp":1794531786332,"version":"4.9.1"},"reference-count":116,"publisher":"Oxford University Press (OUP)","issue":"24","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic kidney disease (CKD), defined per the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines by persistent (\u22653 months) abnormalities of kidney structure or function, including reduced estimated glomerular filtration rate (eGFR) and\/or albuminuria, affects 10%\u201315% of adults worldwide and is a powerful, independent risk factor for cardiovascular diseases, including heart failure (HF). In CKD (stages G1\u2013G3), particularly when accompanied by albuminuria (KDIGO stages A2\u2013A3), even mild reductions in eGFR are associated with subclinical cardiac abnormalities\u2014left ventricular hypertrophy, concentric remodelling, LV diastolic dysfunction, HF with preserved ejection fraction, and arrhythmias. Many CKD patients meet criteria for Stage B HF within the contemporary \u2018pre-HF\u2019 framework, based on structural and functional cardiac alterations and elevated biomarkers in the absence of symptoms. Detection is here challenging, as symptoms are non-specific and circulating biomarkers are confounded by reduced renal clearance. Echocardiography, including speckle-tracking techniques and emerging indices, and cardiac magnetic resonance imaging with tissue characterization and strain analysis are sensitive tools for early diagnosis and risk stratification, but routine screening is not currently recommended in asymptomatic CKD. This condition may be mitigated by aggressive control of traditional and CKD-specific risk factors, and therapies with proven cardiorenal benefits\u2014SGLT2 inhibitors, finerenone, diuretics, renin\u2013angiotensin system blockers, and selected GLP-1 receptor agonists\u2014guide HF prevention. Future research should test cost-effective early diagnostic strategies, clarify the role of imaging and biomarkers in guiding therapy, and exploit multiomics and artificial intelligence to unravel mechanistic heterogeneity and enable personalized prevention of HF in early CKD.<\/jats:p>","DOI":"10.1093\/eurheartj\/ehag220","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T08:56:37Z","timestamp":1774947397000},"page":"3102-3115","source":"Crossref","is-referenced-by-count":4,"title":["Pre-heart failure in early chronic kidney disease: clinical epidemiology and treatment"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6616-1996","authenticated-orcid":false,"given":"Carmine","family":"Zoccali","sequence":"first","affiliation":[{"name":"Renal Research Institute , New York ,","place":["USA"]},{"name":"Institute of Molecular Biology and Genetics (Biogem) , Ariano Irpino ,","place":["Italy"]},{"name":"Associazione Ipertensione Nefrologia Trapianto Renale (IPNET) , Via Torrione 42, Reggio Calabria 89125 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1637-574X","authenticated-orcid":false,"given":"Raffaele","family":"De Caterina","sequence":"additional","affiliation":[{"name":"University of Pisa and Cardiovascular Division, Pisa University Hospital , Via Paradisa, 2, Pisa 56124 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine R","family":"Tuttle","sequence":"additional","affiliation":[{"name":"Providence Medical Research Center , Spokane, WA ,","place":["USA"]},{"name":"Providence Inland Northwest Health , Spokane, WA ,","place":["USA"]},{"name":"Kidney Research Institute and Nephrology Division , Seattle, WA ,","place":["USA"]},{"name":"University of Washington School of Medicine , Seattle, WA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Burnier","sequence":"additional","affiliation":[{"name":"Faculty of Biology and Medicine, University of Lausanne , Lausanne ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5771-5996","authenticated-orcid":false,"given":"Ziad A","family":"Massy","sequence":"additional","affiliation":[{"name":"Nephrology Department, Ambroise Par\u00e9 University Hospital, APHP, Boulogne-Billancourt , Paris ,","place":["France"]},{"name":"Centre for Research in Epidemiology and Population Health (CESP), Paris-Saclay University, Inserm U1018, Versailles Saint-Quentin University, Clinical Epidemiology Team , Villejuif ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Mallamaci","sequence":"additional","affiliation":[{"name":"Associazione Ipertensione Nefrologia Trapianto Renale (IPNET) , Via Torrione 42, Reggio Calabria 89125 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J","family":"Ferro","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine, University Hospitals Birmingham and Institute of Cardiovascular Sciences, University of Birmingham ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7456-1570","authenticated-orcid":false,"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Lorraine, CIC Inserm, CHRU , Nancy ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"2026062219563095500_ehag220-B1","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.kint.2019.07.012","article-title":"A single number for advocacy and communication\u2014worldwide more than 850 million individuals have kidney diseases","volume":"96","author":"Jager","year":"2019","journal-title":"Kidney Int"},{"key":"2026062219563095500_ehag220-B2","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/S0140-6736(25)01853-7","article-title":"Global, regional, and national burden of chronic kidney disease in adults, 1990\u20132023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023","volume":"406","author":"Mark","year":"2025","journal-title":"Lancet"},{"key":"2026062219563095500_ehag220-B3","doi-asserted-by":"publisher","first-page":"414","DOI":"10.2471\/BLT.17.206441","article-title":"The global burden of kidney disease and the sustainable development goals","volume":"96","author":"Luyckx","year":"2018","journal-title":"Bull World Health Organ"},{"key":"2026062219563095500_ehag220-B4","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int"},{"key":"2026062219563095500_ehag220-B5","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1093\/cvr\/cvad083","article-title":"Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association","volume":"119","author":"Zoccali","year":"2023","journal-title":"Cardiovasc Res"},{"key":"2026062219563095500_ehag220-B6","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1093\/ckj\/sfab020","article-title":"Global longitudinal strain by feature-tracking cardiovascular magnetic resonance imaging predicts mortality in patients with end-stage kidney disease","volume":"14","author":"Rankin","year":"2021","journal-title":"Clin Kidney J"},{"key":"2026062219563095500_ehag220-B7","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/eurheartj\/ehv010","article-title":"The kidney in heart failure: an update","volume":"36","author":"Damman","year":"2015","journal-title":"Eur Heart J"},{"key":"2026062219563095500_ehag220-B8","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"2026062219563095500_ehag220-B9","volume-title":"Oxford Textbook of Nephrology","author":"Zoccali","year":"2015","edition":"4th edn"},{"key":"2026062219563095500_ehag220-B10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","article-title":"Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis","volume":"35","author":"Damman","year":"2014","journal-title":"Eur Heart J"},{"key":"2026062219563095500_ehag220-B11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.31083\/j.rcm2504144","article-title":"An updated review of the management of chronic heart failure in patients with Chronic Kidney Disease","volume":"25","author":"Tumelty","year":"2024","journal-title":"Rev Cardiovasc Med"},{"key":"2026062219563095500_ehag220-B12","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1161\/HYPERTENSIONAHA.115.06608","article-title":"Cardiovascular effects of unilateral nephrectomy in living kidney donors","volume":"67","author":"Moody","year":"2016","journal-title":"Hypertension"},{"key":"2026062219563095500_ehag220-B13","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jacc.2003.07.046","article-title":"Heart failure with preserved left ventricular systolic function: epidemiology, clinical characteristics, and prognosis","volume":"43","author":"Hogg","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026062219563095500_ehag220-B14","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1161\/CIRCULATIONAHA.116.024825","article-title":"Contemporary assessment of left ventricular diastolic function in older adults: the Atherosclerosis Risk in Communities Study","volume":"135","author":"Shah","year":"2017","journal-title":"Circulation"},{"key":"2026062219563095500_ehag220-B15","doi-asserted-by":"publisher","first-page":"e008291","DOI":"10.1161\/JAHA.117.008291","article-title":"Left ventricular diastolic dysfunction in the community: impact of diagnostic criteria on the burden, correlates, and prognosis","volume":"7","author":"Nayor","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2026062219563095500_ehag220-B16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jjcc.2009.05.002","article-title":"Left ventricular diastolic dysfunction in the early stage of chronic kidney disease","volume":"54","author":"Otsuka","year":"2009","journal-title":"J Cardiol"},{"key":"2026062219563095500_ehag220-B17","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.cardfail.2006.07.005","article-title":"Left ventricular hypertrophy, and diastolic dysfunction: data from the heart and soul study","volume":"12","author":"Ix","year":"2006","journal-title":"J Card Fail"},{"key":"2026062219563095500_ehag220-B18","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1093\/ndt\/gfu199","article-title":"The association between glomerular filtration rate and left ventricular function in two independent community-based cohorts of elderly","volume":"29","author":"Nerpin","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"2026062219563095500_ehag220-B19","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1681\/ASN.2012020145","article-title":"Associations between kidney function and subclinical cardiac abnormalities in CKD","volume":"23","author":"Park","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2026062219563095500_ehag220-B20","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.5114\/aoms.2014.47822","article-title":"Heart function disturbances in chronic kidney disease\u2014echocardiographic indices","volume":"10","author":"Franczyk-Sk\u00f3ra","year":"2014","journal-title":"Arch Med Sci"},{"key":"2026062219563095500_ehag220-B21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ekir.2018.10.004","article-title":"Left ventricular structure in patients with mild-to-moderate CKD\u2014a Magnetic Resonance Imaging Study","volume":"4","author":"Schneider","year":"2019","journal-title":"Kidney Int Rep"},{"key":"2026062219563095500_ehag220-B22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/cpf.12154","article-title":"Cardiac remodelling and functional alterations in mild-to-moderate renal dysfunction: comparison with healthy subjects","volume":"35","author":"Asp","year":"2015","journal-title":"Clin Physiol Funct Imaging"},{"key":"2026062219563095500_ehag220-B23","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1136\/hrt.2007.137539","article-title":"Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart failure with preserved ejection fraction","volume":"94","author":"Edwards","year":"2008","journal-title":"Heart"},{"key":"2026062219563095500_ehag220-B24","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/j.jacc.2018.03.015","article-title":"Global longitudinal strain: ready for clinical use and guideline implementation\u2217","volume":"71","author":"Haugaa","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026062219563095500_ehag220-B25","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.echo.2008.09.013","article-title":"Subclinical abnormalities of left ventricular myocardial deformation in early-stage chronic kidney disease: the precursor of uremic cardiomyopathy?","volume":"21","author":"Edwards","year":"2008","journal-title":"J Am Soc Echocardiogr"},{"key":"2026062219563095500_ehag220-B26","doi-asserted-by":"publisher","first-page":"e17853","DOI":"10.7717\/peerj.17853","article-title":"Prognostic value of left ventricular structure and strain in chronic kidney disease patients by cardiovascular magnetic resonance imaging: a retrospective study","volume":"12","author":"Zhang","year":"2024","journal-title":"PeerJ"},{"key":"2026062219563095500_ehag220-B27","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1007\/s11255-020-02492-0","article-title":"Prognostic value of left ventricular global longitudinal strain in chronic kidney disease patients: a systematic review and meta-analysis","volume":"52","author":"Zhang","year":"2020","journal-title":"Int Urol Nephrol"},{"key":"2026062219563095500_ehag220-B28","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1161\/CIRCULATIONAHA.112.113233","article-title":"Diastolic dysfunction and risk of atrial fibrillation: a mechanistic appraisal","volume":"126","author":"Rosenberg","year":"2012","journal-title":"Circulation"},{"key":"2026062219563095500_ehag220-B29","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1161\/HYPERTENSIONAHA.119.14258","article-title":"Left ventricular mass and incident chronic kidney disease","volume":"75","author":"Agarwal","year":"2020","journal-title":"Hypertension"},{"key":"2026062219563095500_ehag220-B30","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/ndt\/gfq409","article-title":"Is left ventricular hypertrophy a powerful predictor of progression to dialysis in chronic kidney disease?","volume":"26","author":"Paoletti","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"2026062219563095500_ehag220-B31","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1097\/HJH.0000000000004001","article-title":"The bidirectional link between left ventricular hypertrophy and chronic kidney disease: a cross lagged analysis","volume":"43","author":"Ntounousi","year":"2025","journal-title":"J Hypertens"},{"key":"2026062219563095500_ehag220-B32","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ejhf.2115","article-title":"Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association","volume":"23","author":"Bozkurt","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026062219563095500_ehag220-B33","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1161\/CIRCULATIONAHA.116.022249","article-title":"Heart failure with preserved ejection fraction: a kidney disorder?","volume":"134","author":"Fang","year":"2016","journal-title":"Circulation"},{"key":"2026062219563095500_ehag220-B34","doi-asserted-by":"publisher","first-page":"e011173","DOI":"10.1161\/CIRCHEARTFAILURE.123.011173","article-title":"Risk factors and outcomes associated with heart failure with preserved and reduced ejection fraction in people with Chronic Kidney Disease","volume":"17","author":"Bansal","year":"2024","journal-title":"Circ Heart Fail"},{"key":"2026062219563095500_ehag220-B35","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jchf.2023.01.029","article-title":"Chronic kidney disease, heart failure, and adverse cardiac remodeling in older adults: the ARIC study","volume":"11","author":"Buckley","year":"2023","journal-title":"JACC Heart Fail"},{"key":"2026062219563095500_ehag220-B36","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.2215\/CJN.03890416","article-title":"The agreement between auscultation and lung ultrasound in hemodialysis patients: the LUST study","volume":"11","author":"Torino","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026062219563095500_ehag220-B37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nrneph.2014.243","article-title":"Cardiac imaging in patients with chronic kidney disease","volume":"11","author":"Chiu","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"2026062219563095500_ehag220-B38","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/MNH.0000000000000419","article-title":"Application of echocardiographic data in patients with chronic kidney disease","volume":"27","author":"Dubin","year":"2018","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2026062219563095500_ehag220-B39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s44156-024-00051-2","article-title":"The assessment of left ventricular diastolic function: guidance and recommendations from the British Society of Echocardiography","volume":"11","author":"Robinson","year":"2024","journal-title":"Echo Res Pract"},{"key":"2026062219563095500_ehag220-B40","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jcmg.2018.12.035","article-title":"Myocardial mechanics in patients with normal LVEF and diastolic dysfunction","volume":"13","author":"Bianco","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026062219563095500_ehag220-B41","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.echo.2025.03.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography and for heart failure with preserved ejection fraction diagnosis: an update from the American Society of Echocardiography","volume":"38","author":"Nagueh","year":"2025","journal-title":"J Am Soc Echocardiogr"},{"key":"2026062219563095500_ehag220-B42","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.atherosclerosis.2015.07.013","article-title":"Prevalence and correlates of mitral annular calcification in adults with chronic kidney disease: results from CRIC study","volume":"242","author":"Abd alamir","year":"2015","journal-title":"Atherosclerosis"},{"key":"2026062219563095500_ehag220-B43","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1053\/j.ajkd.2012.07.029","article-title":"Pulmonary hypertension in CKD","volume":"61","author":"Bolignano","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"2026062219563095500_ehag220-B44","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1016\/j.jcmg.2020.04.021","article-title":"Defining myocardial abnormalities across the stages of chronic kidney disease: a Cardiac Magnetic Resonance Imaging Study","volume":"13","author":"Hayer","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026062219563095500_ehag220-B45","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/ehjci\/jeu229","article-title":"Early detection of subclinical left ventricular myocardial dysfunction in patients with chronic kidney disease","volume":"16","author":"Panoulas","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026062219563095500_ehag220-B46","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3904\/kjim.2013.28.1.35","article-title":"Tissue Doppler-derived E\/e\u2019 ratio as a parameter for assessing diastolic heart failure and as a predictor of mortality in patients with chronic kidney disease","volume":"28","author":"Kim","year":"2013","journal-title":"Korean J Intern Med"},{"key":"2026062219563095500_ehag220-B47","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1186\/s12872-023-03474-7","article-title":"Vector flow mapping analysis of left ventricular vortex performance in type 2 diabetic patients with early chronic kidney disease","volume":"23","author":"Chen","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"2026062219563095500_ehag220-B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-025-05058-z","article-title":"Left atrial energy loss as a novel predictor of mortality and cardiovascular events in chronic kidney disease patients with preserved ejection fraction","volume":"25","author":"Chen","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"key":"2026062219563095500_ehag220-B49","doi-asserted-by":"publisher","first-page":"e011608","DOI":"10.1161\/CIRCIMAGING.120.011608","article-title":"Left atrial volumetric\/mechanical coupling Index: a novel predictor of outcome in heart failure with reduced ejection fraction","volume":"14","author":"Benfari","year":"2021","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026062219563095500_ehag220-B50","doi-asserted-by":"publisher","first-page":"e041392","DOI":"10.1161\/JAHA.125.041392","article-title":"Clinical utility of atrioventricular coupling Index in cardiovascular disease","volume":"14","author":"Qin","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"2026062219563095500_ehag220-B51","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41581-023-00747-4","article-title":"Diagnosis of cardiovascular disease in patients with chronic kidney disease","volume":"19","author":"Zoccali","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"2026062219563095500_ehag220-B52","doi-asserted-by":"publisher","first-page":"I123","DOI":"10.1093\/eurheartjsupp\/suac085","article-title":"Clinical implications of cardiac magnetic resonance imaging fibrosis","volume":"24","author":"Guglielmo","year":"2022","journal-title":"Eur Heart J Suppl"},{"key":"2026062219563095500_ehag220-B53","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12872-019-1256-3","article-title":"Myocardial characterization in pre-dialysis chronic kidney disease: a study of prevalence, patterns and outcomes","volume":"19","author":"Price","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"key":"2026062219563095500_ehag220-B54","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/jmri.27529","article-title":"Texture analysis of native T1 images as a novel method for noninvasive assessment of uremic cardiomyopathy","volume":"54","author":"Zhou","year":"2021","journal-title":"J Magn Reson Imaging"},{"key":"2026062219563095500_ehag220-B55","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00247-016-3741-5","article-title":"Magnetic resonance tissue phase mapping demonstrates altered left ventricular diastolic function in children with chronic kidney disease","volume":"47","author":"Gimpel","year":"2017","journal-title":"Pediatr Radiol"},{"key":"2026062219563095500_ehag220-B56","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1681\/ASN.2014010108","article-title":"High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the chronic renal insufficiency cohort (CRIC) study","volume":"26","author":"Bansal","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2026062219563095500_ehag220-B57","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jchf.2024.08.009","article-title":"Natriuretic peptides, kidney function, and clinical outcomes in heart failure with preserved ejection fraction","volume":"13","author":"Neuen","year":"2025","journal-title":"JACC Heart Fail"},{"key":"2026062219563095500_ehag220-B58","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.jchf.2022.12.005","article-title":"Reclassification of Pre-heart failure stages using cardiac biomarkers: the ARIC study","volume":"11","author":"Jia","year":"2023","journal-title":"JACC Heart Fail"},{"key":"2026062219563095500_ehag220-B59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41371-022-00751-4","article-title":"Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations","volume":"37","author":"Law","year":"2023","journal-title":"J Hum Hypertens"},{"key":"2026062219563095500_ehag220-B60","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.hfc.2017.02.005","article-title":"Heart failure with preserved ejection fraction in older adult","volume":"13","author":"Upadhya","year":"2017","journal-title":"Heart Fail Clin"},{"key":"2026062219563095500_ehag220-B61","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureDeveloped by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026062219563095500_ehag220-B62","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/ejhf.3024","article-title":"2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"26","author":"McDonagh","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026062219563095500_ehag220-B63","doi-asserted-by":"publisher","first-page":"E895","DOI":"10.1161\/CIR.0000000000001063","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"2026062219563095500_ehag220-B64","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3390\/toxins17110541","article-title":"Furosemide and the symptom burden: the potential mediating role of uremic toxins in patients with CKD","volume":"17","author":"Costes-Albrespic","year":"2025","journal-title":"Toxins (Basel)"},{"key":"2026062219563095500_ehag220-B65","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3390\/biomedicines13030608","article-title":"The role of SGLT2-inhibitors across all stages of heart failure and mechanisms of early clinical benefit: from prevention to advanced heart failure","volume":"13","author":"Crispino","year":"2025","journal-title":"Biomedicines"},{"key":"2026062219563095500_ehag220-B66","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"2026062219563095500_ehag220-B67","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"The EMPA-KIDNEY Collaborative Group","year":"2023","journal-title":"N Engl J Med"},{"key":"2026062219563095500_ehag220-B68","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"2026062219563095500_ehag220-B69","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"2026062219563095500_ehag220-B70","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"2026062219563095500_ehag220-B71","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2025.09.022","article-title":"Effects of empagliflozin on kidney and cardiac magnetic resonance imaging measures in patients with CKD: an EMPA-KIDNEY mechanistic substudy","author":"Zhu","year":"2025","journal-title":"Am J Kidney Dis"},{"key":"2026062219563095500_ehag220-B72","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1001\/jama.2015.17346","article-title":"Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomized clinical trial","volume":"315","author":"Kitzman","year":"2016","journal-title":"JAMA"},{"key":"2026062219563095500_ehag220-B73","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.jacc.2025.06.055","article-title":"The adipokine hypothesis of heart failure with a preserved ejection fraction: a novel framework to explain pathogenesis and guide treatment","volume":"86","author":"Packer","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"2026062219563095500_ehag220-B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.soard.2021.09.009","article-title":"Bariatric surgery decreases the number of future hospital admissions for diastolic heart failure in subjects with severe obesity: a retrospective analysis of the US National Inpatient Sample database","volume":"18","author":"Romero Funes","year":"2022","journal-title":"Surg Obes Relat Dis"},{"key":"2026062219563095500_ehag220-B75","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1093\/ckj\/sfaa266","article-title":"Renoprotective role of bariatric surgery in patients with established chronic kidney disease","volume":"14","author":"Morales","year":"2020","journal-title":"Clin Kidney J"},{"key":"2026062219563095500_ehag220-B76","doi-asserted-by":"publisher","first-page":"e038191","DOI":"10.1161\/JAHA.124.038191","article-title":"Reduced risk of cardiovascular diseases after bariatric surgery based on the new predicting risk of cardiovascular disease EVENTs equations","volume":"14","author":"Wang","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"2026062219563095500_ehag220-B77","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s40620-024-02049-9","article-title":"Physical activity and exercise in chronic kidney disease: consensus statements from the physical exercise working group of the Italian Society of Nephrology","volume":"37","author":"Battaglia","year":"2024","journal-title":"J Nephrol"},{"key":"2026062219563095500_ehag220-B78","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"2026062219563095500_ehag220-B79","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1038\/s41591-024-03015-5","article-title":"Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial","volume":"30","author":"Colhoun","year":"2024","journal-title":"Nat Med"},{"key":"2026062219563095500_ehag220-B80","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S0140-6736(24)01498-3","article-title":"Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial","volume":"404","author":"Deanfield","year":"2024","journal-title":"Lancet"},{"key":"2026062219563095500_ehag220-B81","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.jacc.2024.08.004","article-title":"Effects of semaglutide on heart failure outcomes in diabetes and chronic kidney disease in the FLOW trial","volume":"84","author":"Pratley","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026062219563095500_ehag220-B82","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"2026062219563095500_ehag220-B83","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1056\/NEJMoa2313917","article-title":"Semaglutide in patients with obesity-related heart failure and type 2 diabetes","volume":"390","author":"Kosiborod","year":"2024","journal-title":"N Engl J Med"},{"key":"2026062219563095500_ehag220-B84","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1161\/CIRCULATIONAHA.119.041659","article-title":"Effect of once-weekly exenatide in patients with type 2 diabetes Mellitus with and without heart failure and heart failure-related outcomes: insights from the EXSCEL trial","volume":"140","author":"Fudim","year":"2019","journal-title":"Circulation"},{"key":"2026062219563095500_ehag220-B85","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"381","author":"Husain","year":"2019","journal-title":"N Engl J Med"},{"key":"2026062219563095500_ehag220-B86","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"2026062219563095500_ehag220-B87","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1056\/NEJMoa1612917","article-title":"Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes","volume":"377","author":"Holman","year":"2017","journal-title":"N Engl J Med"},{"key":"2026062219563095500_ehag220-B88","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/S0140-6736(18)32261-X","article-title":"Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (harmony outcomes): a double-blind, randomised placebo-controlled trial","volume":"392","author":"Hernandez","year":"2018","journal-title":"Lancet"},{"key":"2026062219563095500_ehag220-B89","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"2026062219563095500_ehag220-B90","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"2026062219563095500_ehag220-B91","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1056\/NEJMoa1509225","article-title":"Lixisenatide in patients with type 2 diabetes and acute coronary syndrome","volume":"373","author":"Pfeffer","year":"2015","journal-title":"N Engl J Med"},{"key":"2026062219563095500_ehag220-B92","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"key":"2026062219563095500_ehag220-B93","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"key":"2026062219563095500_ehag220-B94","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jacc.2019.11.003","article-title":"Prior heart failure hospitalization, clinical outcomes, and response to sacubitril\/valsartan compared with Valsartan in HFpEF","volume":"75","author":"Vaduganathan","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026062219563095500_ehag220-B95","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1038\/s41591-024-03263-5","article-title":"Low-dose spironolactone and cardiovascular outcomes in moderate stage chronic kidney disease: a randomized controlled trial","volume":"30","author":"Hobbs","year":"2024","journal-title":"Nat Med"},{"key":"2026062219563095500_ehag220-B96","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N Engl J Med"},{"key":"2026062219563095500_ehag220-B97","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"key":"2026062219563095500_ehag220-B98","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1093\/eurheartj\/ehab777","article-title":"Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis","volume":"43","author":"Agarwal","year":"2022","journal-title":"Eur Heart J"},{"key":"2026062219563095500_ehag220-B99","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.cardfail.2019.11.009","article-title":"Homage proof of concept trial of spironolactone for the prevention of heart failure","volume":"25","author":"Zannad","year":"2019","journal-title":"J Card Fail"},{"key":"2026062219563095500_ehag220-B100","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/jcrm1010004","article-title":"Obesity and chronic kidney disease: a comprehensive review of mechanisms, impact, and management strategies","volume":"1","author":"Shirsat","year":"2025","journal-title":"J CardioRenal Med"},{"key":"2026062219563095500_ehag220-B101","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1016\/j.jacc.2025.08.036","article-title":"Central adiposity or hypertension: which drives heart failure with a preserved ejection fraction?","volume":"86","author":"Packer","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"2026062219563095500_ehag220-B102","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/j.cjca.2025.02.016","article-title":"Integrative omics approaches in cardiovascular disease research: current trends and future directions","volume":"41","author":"Saboktakin Rizi","year":"2025","journal-title":"Can J Cardiol"},{"key":"2026062219563095500_ehag220-B103","doi-asserted-by":"publisher","first-page":"1125687","DOI":"10.3389\/fcvm.2023.1125687","article-title":"Inflammation as a therapeutic target in heart failure with preserved ejection fraction","volume":"10","author":"Peh","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"2026062219563095500_ehag220-B104","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.cardfail.2023.10.024","article-title":"HERMES: effects of Ziltivekimab versus placebo on morbidity and mortality in patients with heart failure with mildly reduced or preserved ejection fraction and systemic inflammation","volume":"30","author":"Petrie","year":"2024","journal-title":"J Card Fail"},{"key":"2026062219563095500_ehag220-B105","doi-asserted-by":"publisher","first-page":"e002360","DOI":"10.1136\/openhrt-2023-002360","article-title":"Colchicine in patients with heart failure and preserved left ventricular ejection fraction: rationale and design of a prospective, randomised, open-label, crossover clinical trial","volume":"10","author":"Shchendrygina","year":"2023","journal-title":"Open Heart"},{"key":"2026062219563095500_ehag220-B106","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/s12967-025-06425-2","article-title":"Machine learning and multi-omics integration: advancing cardiovascular translational research and clinical practice","volume":"23","author":"Lin","year":"2025","journal-title":"J Transl Med"},{"key":"2026062219563095500_ehag220-B107","doi-asserted-by":"publisher","first-page":"H1524","DOI":"10.1152\/ajpheart.00955.2010","article-title":"The onset of left ventricular diastolic dysfunction in SHR rats is not related to hypertrophy or hypertension","volume":"302","author":"Dupont","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026062219563095500_ehag220-B108","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s42003-022-04278-9","article-title":"A maladaptive feedback mechanism between the extracellular matrix and cytoskeleton contributes to hypertrophic cardiomyopathy pathophysiology","volume":"6","author":"Viola","year":"2023","journal-title":"Commun Biol"},{"key":"2026062219563095500_ehag220-B109","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1113\/JP271681","article-title":"The L-type Ca2 + channel facilitates abnormal metabolic activity in the cTnI-G203S mouse model of hypertrophic cardiomyopathy","volume":"594","author":"Viola","year":"2016","journal-title":"J Physiol"},{"key":"2026062219563095500_ehag220-B110","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41569-025-01167-6","article-title":"Mechano-energetic uncoupling in heart failure","volume":"22","author":"Aksentijevic","year":"2025","journal-title":"Nat Rev Cardiol"},{"key":"2026062219563095500_ehag220-B111","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ahj.2008.01.035","article-title":"Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy","volume":"156","author":"Rold\u00e1n","year":"2008","journal-title":"Am Heart J"},{"key":"2026062219563095500_ehag220-B112","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/01.CIR.98.6.535","article-title":"Abnormalities of the extracellular degradation of collagen type I in essential hypertension","volume":"98","author":"Laviades","year":"1998","journal-title":"Circulation"},{"key":"2026062219563095500_ehag220-B113","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jacc.2006.02.055","article-title":"Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction. Results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial","volume":"48","author":"Hudson","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026062219563095500_ehag220-B114","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1093\/eurheartj\/ehaf316","article-title":"Finerenone effects on biomarkers: an analysis from the FIGARO-DKD trial","volume":"46","author":"Berger","year":"2025","journal-title":"Eur Heart J"},{"key":"2026062219563095500_ehag220-B115","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/ejhf.3202","article-title":"Proteomic profiles of left atrial volume and its influence on response to spironolactone: findings from the HOMAGE trial and STANISLAS cohort","volume":"26","author":"Kobayashi","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026062219563095500_ehag220-B116","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1161\/CIRCULATIONAHA.108.797407","article-title":"Mechanisms of aortic and cardiac dysfunction in uremic mice with aortic calcification","volume":"119","author":"Maizel","year":"2009","journal-title":"Circulation"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/24\/3102\/67681842\/ehag220.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/24\/3102\/67681842\/ehag220.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T23:56:40Z","timestamp":1782172600000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/47\/24\/3102\/8566011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":116,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2026,3,31]]},"published-print":{"date-parts":[[2026,6,23]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehag220","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6,21]]},"published":{"date-parts":[[2026,3,31]]}}}